Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue, net $ 5,446 $ 6,270 $ 14,504 $ 12,280
Cost of revenue (excluding amortization of $1,115 and $897, for the three months and $2,230 and $1,794 for the six months, respectively) 3,850 3,031 9,963 5,654
Gross profit 1,596 3,239 4,541 6,626
Operating expenses:        
Sales and marketing 1,596 2,959 4,077 5,369
Research and development 550 647 1,360 1,175
General and administrative 4,107 2,788 8,999 5,122
Acquisition related expense 1,295 1,696
Acquisition amortization expense 1,115 897 2,230 1,794
Total operating expenses 7,368 8,586 16,666 15,156
Operating loss (5,772) (5,347) (12,125) (8,530)
Interest accretion (167) (91) (276) (220)
Other income (expense), net 438 74 485 123
Loss from continuing operations before tax (5,501) (5,364) (11,916) (8,627)
Provision for income taxes 13 5 28 10
Loss from continuing operations, net of tax (5,514) (5,369) (11,944) (8,637)
(Loss) income from discontinued operations, net of tax (66) 65 (130) 7
Net loss (5,580) (5,304) (12,074) (8,630)
Less adjustment for preferred stock deemed dividend (3,033)
Net loss attributable to common stockholders $ (5,580) $ (5,304) $ (15,107) $ (8,630)
Basic and diluted loss per share of common stock:        
From continuing operations $ (1.37) $ (1.41) $ (3.73) $ (2.36)
From discontinued operations (0.01) 0.02 (0.03)
Net loss per basic and diluted share of common stock $ (1.38) $ (1.39) $ (3.76) $ (2.36)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 4,033,000 3,813,000 4,018,000 3,665,000
Diluted 4,033,000 3,813,000 4,018,000 3,665,000